Experimental analysis shows plant-derived galloyl glucosides restore gut microbiome dysbiosis in colitis mice, suggesting a novel therapeutic avenue for inflammatory bowel disease.
Key Points
Treatment with galloyl glucosides led to significant restoration of the imbalanced gut microbiome in colitis mice, aiding in recovery.
Colitis caused major changes in microbial composition, while treatment with the compounds improved functional pathways and microbial balance.
Investigation involved PacBio HiFi sequencing of the 16S rRNA gene from mouse colon tissue to examine microbiome alterations.
Findings underscore the potential of plant-derived compounds as promising therapies for IBD, emphasizing the connection between microbiome health and host immunity.